R.L. Siegel, K.D. Miller, S.A. Fedewa, D.J. Ahnen, R.G.S. Meester, A. Barzi, A. Jemal, Colorectal cancer statistics, 2017, CA: A Cancer Journal for Clinicians, 67 (2017) 177-193.
 M. Arnold, M.S. Sierra, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66 (2017) 683-691.
 E. Van Cutsem, A. Cervantes, B. Nordlinger, D. Arnold, Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of oncology, 25 (2014) iii1-iii9.
 M.G. Fakih, Metastatic Colorectal Cancer: Current State and Future Directions, Journal of Clinical Oncology, 33 (2015) 1809-1824.
 H. Ling, K. Pickard, C. Ivan, C. Isella, M. Ikuo, R. Mitter, R. Spizzo, M.D. Bullock, C. Braicu, V. Pileczki, The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis, Gut, 65 (2016) 977-989.
 Z. Obermeyer, E.J. Emanuel, Predicting the future—big data, machine learning, and clinical medicine, The New England journal of medicine, 375 (2016) 1216.
 A.M. Bur, M. Shew, J. New, Artificial intelligence for the otolaryngologist: a state of the art review, Otolaryngology–Head and Neck Surgery, 160 (2019) 603-611.
 J.T. Senders, P.C. Staples, A.V. Karhade, M.M. Zaki, W.B. Gormley, M.L.D. Broekman, T.R. Smith, O. Arnaout, Machine Learning and Neurosurgical Outcome Prediction: A Systematic Review, World Neurosurgery, 109 (2018) 476-486.e471.
 A.M. Bur, A. Holcomb, S. Goodwin, J. Woodroof, O. Karadaghy, Y. Shnayder, K. Kakarala, J. Brant, M. Shew, Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma, Oral Oncology, 92 (2019) 20-25.
 J. Zhi, J. Sun, Z. Wang, W. Ding, Support vector machine classifier for prediction of the metastasis of colorectal cancer, International journal of molecular medicine, 41 (2018) 1419-1426.
 P. Azimi, H.R. Mohammadi, E.C. Benzel, S. Shahzadi, S. Azhari, A. Montazeri, Artificial neural networks in neurosurgery, Journal of Neurology, Neurosurgery &amp; Psychiatry, 86 (2015) 251.
 J. Faradmal, A.R. Soltanian, G. Roshanaei, R. Khodabakhshi, A. Kasaeian, Comparison of the performance of log-logistic regression and artificial neural networks for predicting breast cancer relapse, Asian Pac J Cancer Prev, 15 (2014) 5883-5888.
 E. Saus, A. Brunet-Vega, S. Iraola-Guzmán, C. Pegueroles, T. Gabaldón, C. Pericay, Long non-coding RNAs as potential novel prognostic biomarkers in colorectal cancer, Frontiers in genetics, 7 (2016) 54.
 I. Garajová, M. Ferracin, E. Porcellini, A. Palloni, F. Abbati, G. Biasco, G. Brandi, Non-coding RNAs as predictive biomarkers to current treatment in metastatic colorectal cancer, International journal of molecular sciences, 18 (2017) 1547.
 F. Schmid, Q. Wang, M. Huska, M. Andrade-Navarro, M. Lemm, I. Fichtner, M. Dahlmann, D. Kobelt, W. Walther, J. Smith, SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival, Oncogene, 35 (2016) 5942-5952.
 A. Biglarian, E. Bakhshi, M.R. Gohari, R. Khodabakhshi, Artificial neural network for prediction of distant metastasis in colorectal cancer, Asian Pacific Journal of Cancer Prevention, 13 (2012) 927-930.
 S. Rajagopalan, E.O. Long, KIR2DL4 (CD158d): an activation receptor for HLA-G, Frontiers in immunology, 3 (2012) 258.
 T.R. Kataoka, C. Ueshima, M. Hirata, S. Minamiguchi, H. Haga, Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis, International Journal of Molecular Sciences, 21 (2020) 954.
 I. Zidi, N.B. Amor, HLA-G as predisposing for metastasis, Medical hypotheses, 77 (2011) 134-139.
 D.M. Ferns, A.M. Heeren, S. Samuels, M.C. Bleeker, T.D. de Gruijl, G.G. Kenter, E.S. Jordanova, Classical and non-classical HLA class I aberrations in primary cervical squamous-and adenocarcinomas and paired lymph node metastases, Journal for immunotherapy of cancer, 4 (2016) 78.
 L.M. Nunes, F.M. Ayres, I.C.M. Francescantonio, V.A. Saddi, M.A.G. Avelino, R.d.C.G. Alencar, R.C.d. Silva, A.J. Meneghini, I.J. Wastowski, Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer, Human Immunology, 74 (2013) 447-451.
 M. Swets, M.H. König, A. Zaalberg, N.G. Dekker-Ensink, H. Gelderblom, C.J.H. van de Velde, P.J. van den Elsen, P.J.K. Kuppen, HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases, Human Immunology, 77 (2016) 773-779.
 A. Lin, W.-H. Yan, Human leukocyte antigen-G (HLA-G) expression in cancers: roles in immune evasion, metastasis and target for therapy, Molecular Medicine, 21 (2015) 782-791.
 C. Ueshima, T.R. Kataoka, M. Hirata, A. Furuhata, E. Suzuki, M. Toi, T. Tsuruyama, Y. Okayama, H. Haga, The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion, Cancer immunology research, 3 (2015) 871-880.
 A. Mitchell, S.L. Hasanali, D.S. Morera, R. Baskar, X. Wang, R. Khan, A. Talukder, C.S. Li, M. Manoharan, A.R. Jordan, A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients, Cancer Biomarkers, (2019) 1-11.
 Y. Itatani, K. Kawada, S. Inamoto, T. Yamamoto, R. Ogawa, M.M. Taketo, Y. Sakai, The role of chemokines in promoting colorectal cancer invasion/metastasis, International journal of molecular sciences, 17 (2016) 643.
 A. Zipin-Roitman, T. Meshel, O. Sagi-Assif, B. Shalmon, C. Avivi, R.M. Pfeffer, I.P. Witz, A. Ben-Baruch, CXCL10 Promotes Invasion-Related Properties in Human Colorectal Carcinoma Cells, Cancer Research, 67 (2007) 3396.
 R. Tokunaga, W. Zhang, M. Naseem, A. Puccini, M.D. Berger, S. Soni, M. McSkane, H. Baba, H.-J. Lenz, CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy, Cancer Treatment Reviews, 63 (2018) 40-47.
 O. Grip, S. Janciauskiene, Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease, PLoS One, 4 (2009) e5263-e5263.
 G. Ferreira, A. Teixeira, E. Sato, Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus, Lupus, 19 (2010) 927-934.
 M. Zhou, J. Zheng, J. Bi, X. Wu, J. Lyu, K. Gao, Synergistic inhibition of colon cancer cell growth by a combination of atorvastatin and phloretin, Oncology letters, 15 (2018) 1985-1992.
 K. Gumireddy, A. Li, A.V. Kossenkov, M. Sakurai, J. Yan, Y. Li, H. Xu, J. Wang, P.J. Zhang, L. Zhang, L.C. Showe, K. Nishikura, Q. Huang, The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis, Nature Communications, 7 (2016) 10715.
 M. Vithlani, M. Terunuma, S.J. Moss, The dynamic modulation of GABAA receptor trafficking and its role in regulating the plasticity of inhibitory synapses, Physiological reviews, 91 (2011) 1009-1022.
 H. Azuma, T. Inamoto, T. Sakamoto, S. Kiyama, T. Ubai, Y. Shinohara, K. Maemura, M. Tsuji, N. Segawa, H. Masuda, γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism, Cancer research, 63 (2003) 8090-8096.
 P.H. Thaker, K. Yokoi, N.B. Jennings, Y. Li, R.B. Rebhun, D.L. Rousseau Jr, D. Fan, A.K. Sood, Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal, Cancer biology & therapy, 4 (2005) 753-758.
 L. Liu, C. Yang, J. Shen, L. Huang, W. Lin, H. Tang, W. Liang, W. Shao, H. Zhang, J. He, GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases, Oncotarget, 7 (2016) 32341.
 C. Stock, A. Schwab, Ion channels and transporters in metastasis, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1848 (2015) 2638-2646.
 S. Martial, Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis, American Journal of Physiology-Cell Physiology, 310 (2016) C710-C727.
 M.B. Djamgoz, R.C. Coombes, A. Schwab, Ion transport and cancer: from initiation to metastasis, in, The Royal Society, 2014.
 C.L. Dixon, N.L. Harrison, J.W. Lynch, A. Keramidas, Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity, British journal of pharmacology, 172 (2015) 3522-3536.
 S.V. Fox, A.L. Gotter, S.J. Tye, S.L. Garson, A.T. Savitz, J.M. Uslaner, J.I. Brunner, P.L. Tannenbaum, T.P. McDonald, R. Hodgson, Quantitative electroencephalography within sleep/wake states differentiates GABA A modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats, Neuropsychopharmacology, 38 (2013) 2401-2408.